Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?
Rigel Pharmaceuticals Ownership Summary
Rigel Pharmaceuticals is owned by 13.28% institutional investors, 2.43% insiders, and 84.29% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.23% of RIGL shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 4.07% of its assets in Rigel Pharmaceuticals shares.
RIGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rigel Pharmaceuticals | 13.28% | 2.43% | 84.29% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 1.66M | 9.23% | $71.28M |
| Vanguard group | 1.04M | 5.76% | $44.48M |
| Armistice capital | 724.00K | 4.05% | $20.51M |
| Goldman sachs group | 671.88K | 3.72% | $28.78M |
| Marshall wace, llp | 601.33K | 3.36% | $17.04M |
| Capitolis liquid global markets | 591.55K | 3.31% | $16.76M |
| State street | 554.32K | 3.10% | $15.70M |
| Lsv asset management | 544.28K | 3.02% | $23.31M |
| Renaissance | 539.01K | 2.99% | $23.09M |
| Acadian asset management | 493.60K | 2.74% | $21.13M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cm management | 225.00K | 8.12% | $9.64M |
| Globeflex capital l p | 217.84K | 1.43% | $9.33M |
| Empire financial management company | 76.44K | 0.71% | $3.27M |
| Range financial group | 45.94K | 0.68% | $1.97M |
| Hussman strategic advisors | 52.50K | 0.54% | $2.25M |
| Soleus capital management | 300.03K | 0.47% | $12.85M |
| Hillsdale investment management | 282.58K | 0.33% | $12.10M |
| Pharvision advisers | 20.52K | 0.33% | $581.39K |
| Armistice capital | 724.00K | 0.30% | $20.51M |
| Wakefield asset management lllp | 25.65K | 0.30% | $1.10M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lsv asset management | 544.28K | 0.05% | 433.38K |
| Marshall wace, llp | 601.33K | 0.02% | 232.38K |
| Arrowstreet capital, limited partnership | 413.66K | 0.01% | 227.33K |
| Qube research | 360.97K | 0.01% | 189.54K |
| Two sigma investments, lp | 220.30K | 0.01% | 181.96K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | - | - | -14.80M |
| Nuveen asset management | - | - | -3.22M |
| Jacobs levy equity management | - | - | -2.29M |
| Healthcare of ontario pension plan trust fund | - | - | -1.36M |
| Stonepine capital management | - | - | -1.04M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Schroder investment management group | 71.82K | 0.00% | 71.82K | $2.06B |
| First trust advisors lp | 57.62K | 0.00% | 57.62K | $1.63M |
| Universal- beteiligungs- und servicegesellschaft mbh | 55.20K | 0.00% | 55.20K | $2.36M |
| Hussman strategic advisors | 52.50K | 0.54% | 52.50K | $2.25M |
| Hennion & walsh asset management | 52.19K | 0.08% | 52.19K | $2.24M |
Sold Out
| Holder | Change |
|---|---|
| Financial consulate | -10.00 |
| Synergy asset management | -15.00 |
| Strategic investment solutions, inc. /il | -25.00 |
| Harbour investments | -40.00 |
| Gps wealth strategies group | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 45 | -73.53% | 2,395,282 | -84.02% | 13 | 0.19% | 33 | -68.27% | 9 | -80.43% |
| Sep 30, 2025 | 48 | -61.29% | 2,467,259 | -82.23% | 13 | 0.23% | 24 | -61.90% | 14 | -61.11% |
| Jun 30, 2025 | 123 | 0.82% | 13,882,606 | -0.14% | 77 | 1.27% | 62 | -3.13% | 36 | -5.26% |
| Mar 31, 2025 | 3 | -97.60% | 1,156,951 | -90.41% | 6 | 0.14% | 1 | -98.78% | 1 | -95.24% |
| Dec 31, 2024 | 6 | 50.00% | 1,212 | 65.35% | - | 39369.05% | 2 | 100.00% | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 738.73K | 4.07% | -3.98K |
| Vanguard US Total Market Shares ETF | 548.78K | 3.07% | - |
| Vanguard Total Stock Mkt Idx Inv | 542.05K | 2.99% | 6.80K |
| iShares Russell 2000 ETF | 428.34K | 2.36% | 59.60K |
| Avantis US Small Cap Value ETF | 417.88K | 2.30% | 1.17K |
| GS Glb Sm Cp CORE Eq Base Inc USD Close | 290.18K | 1.60% | - |
| SPDR® S&P Biotech ETF | 223.01K | 1.24% | 500.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 195.09K | 1.07% | -1.51K |
| Lazard US Sm Cap Eq WW Dist EUR | 176.06K | 0.98% | 27.20K |
| Fidelity Small Cap Index | 177.76K | 0.98% | 783.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 20, 2026 | MOOS WALTER H | - | Sell | $145.44K |
| Feb 05, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $38.02K |
| Feb 04, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $42.60K |
| Feb 04, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | $44.46K |
| Feb 05, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | $39.38K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 8 |
RIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools